GlaxoSmithKline (GSK) today announced further progress on its commitment to reinvest 20% of profits made in the Least Developed Countries (LDCs) back into projects that strengthen the healthcare infrastructure in those countries. GSK has formed a new partnership with three leading NGOs to deliver the reinvestments in LDCs: AMREF in East and Southern Africa, CARE International UK in Asia Pacific and Save the Children in West Africa. The shared objective of the investments will be to improve health outcomes by supporting frontline health workers who operate in these countries...Andrew Witty, CEO of GSK said: “.. Although the profits we make in LDCs are relatively small at this time, our commitment to reinvest 20% of them provides a sustainable model to help improve healthcare infrastructure ...We are pleased to partner with three respected NGOs...to deliver solutions that can make a difference .. in the world’s poorest countries”...